{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:56:04Z","timestamp":1792727764942,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijrobp.2022.09.071","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:36:53Z","timestamp":1664325413000},"page":"1165-1177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["One-Year Treatment-Related Side Effects and Quality of Life After Chemoradiotherapy in Squamous Cell Carcinoma of the Anus"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-4677","authenticated-orcid":false,"given":"Anna Cecilie","family":"Lef\u00e8vre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serup-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Smedegaard","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Lycke","family":"Wind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Kronborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen-Lise Garm","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.09.071_bib0001","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0003","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0004","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0006","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/codi.14103","article-title":"Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)","volume":"20","author":"Fish","year":"2018","journal-title":"Color Dis"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0007","first-page":"3613","article-title":"Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy","volume":"23","author":"Sodergren","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0008","doi-asserted-by":"crossref","first-page":"O230","DOI":"10.1111\/codi.13076","article-title":"Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: A Danish multicentre cross-sectional questionnaire study","volume":"17","author":"Sunesen","year":"2015","journal-title":"Color Dis"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0009","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrclinonc.2015.218","article-title":"Squamous-cell carcinoma of the anus: Progress in radiotherapy treatment","volume":"13","author":"Glynne-Jones","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0011","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0300891618811273","article-title":"Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects","volume":"105","author":"Koerber","year":"2019","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0012","doi-asserted-by":"crossref","first-page":"e1524","DOI":"10.1200\/OP.20.00122","article-title":"Patient-reported GI outcomes in patients with anal cancer receiving modern chemoradiation","volume":"16","author":"Kouzy","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","article-title":"Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer","volume":"90","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0014","first-page":"39","article-title":"Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal","volume":"6","author":"Chuong","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0015","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.30527","article-title":"Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care","volume":"123","author":"Frick","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2019.11.016","article-title":"Long-term follow-up experience in anal canal cancer treated with intensity modulated radiation therapy: Clinical outcomes, patterns of relapse and predictors of failure","volume":"144","author":"de Meric de Bellefon","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2021.01.027","article-title":"Anorectal function and radiation dose to pelvic floor muscles after primary treatment for anal cancer","volume":"157","author":"Kronborg","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.12.022","article-title":"UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes","volume":"128","author":"Gilbert","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0019","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/codi.15590","article-title":"Long-term bowel function patient-reported outcomes after successful chemoradiation for carcinoma of the anal canal","volume":"23","author":"Shaw","year":"2021","journal-title":"Color Dis"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0020","first-page":"4169","article-title":"Patient-reported QoL in anal cancer survivors 3 and 6 years after treatment\u2014Results from the Swedish national ANCA study","volume":"30","author":"Axelsson","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0021","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2468-1253(18)30264-4","article-title":"A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): A patient and health care professional consensus","volume":"3","author":"Fish","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0022","first-page":"3669","article-title":"The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): A systematic review","volume":"24","author":"Atkinson","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0023","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.radonc.2018.06.006","article-title":"Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimization","volume":"128","author":"Kronborg","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0024","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10269-006-0412-4","article-title":"Quality of life assessment and research in the EORTC (European Organisation for Research and Treatment of Cancer)","volume":"8","author":"Flechtner","year":"2006","journal-title":"Oncologie"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"111","author":"Glynne-Jones","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0026","unstructured":"Danish Anal Cancer Group. Clinical guidelines. Available at: https:\/\/dacgnet.dk\/kliniske-retningslinjer\/. Accessed October 19, 2022."},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0027","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.3390\/cancers13133226","article-title":"Intensified induction chemotherapy in locally advanced squamous cell carcinoma of the anus\u2014A population-based experience from the Danish Anal cancer group","volume":"13","author":"Wind","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0028","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ejca.2009.08.014","article-title":"Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer","volume":"45","author":"Whistance","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0029","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of- life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0030","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s11136-014-0675-y","article-title":"Danish population-based reference data for the EORTC QLQ-C30: Associations with gender, age and morbidity","volume":"23","author":"Juul","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0031","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0032","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ejso.2019.01.181","article-title":"Quality of life following salvage surgery for squamous cell carcinoma of the anus","volume":"45","author":"Pedersen","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0033","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-8140(99)00096-1","article-title":"Curative-intent radiation therapy in anal carcinoma: Quality of life and sphincter function","volume":"52","author":"Vordermark","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0034","first-page":"801588","article-title":"Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy","author":"Allal","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0035","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.24906","article-title":"Long-term quality of life after radiotherapy for the treatment of anal cancer","volume":"116","author":"Das","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0036","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00066-013-0314-5","article-title":"Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients: A single institution experience and review of the literature","volume":"189","author":"Fakhrian","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0037","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00066-010-2175-5","article-title":"Quality of life outcomes in patients with anal cancer after combined radiochemotherapy","volume":"187","author":"Welzel","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0038","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2013.05.037","article-title":"Fecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort","volume":"108","author":"Bentzen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0039","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clon.2004.05.007","article-title":"Quality of life after non-surgical treatment of anal carcinoma: A case control study of long-term survivors","volume":"16","author":"Jephcott","year":"2004","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.radonc.2018.04.012","article-title":"Abnormal neuronal response to rectal and anal stimuli in patients treated with primary radiotherapy for anal cancer","volume":"128","author":"Haas","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0041","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejon.2015.02.007","article-title":"Late effects and quality of life after chemo-radiation for the treatment of anal cancer","volume":"19","author":"Knowles","year":"2015","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0042","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.radonc.2016.06.020","article-title":"Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer","volume":"120","author":"Joseph","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0043","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/annonc\/mds539","article-title":"The FACT-G7: A rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research","volume":"24","author":"Yanez","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3393\/ac.2015.31.1.23","article-title":"Predictors of fecal incontinence and related quality of life after a total mesorectal excision with primary anastomosis for patients with rectal cancer","volume":"31","author":"Walma","year":"2015","journal-title":"Ann Coloproctol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41687-020-0181-7","article-title":"Development and validation of an interpretive guide for PROMIS scores","volume":"4","author":"Rothrock","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0046","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2036.2004.02028.x","article-title":"A new questionnaire for constipation and fecal incontinence","volume":"20","author":"Bharucha","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0047","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/BF02236199","article-title":"Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: The fecal incontinence severity index","volume":"42","author":"Rockwood","year":"1999","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0048","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/DCR.0000000000000758","article-title":"Anorectal function and quality of life in patients with early stage rectal cancer treated with chemoradiation and local excision","volume":"60","author":"Lynn","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0049","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1463-1318.2010.02244.x","article-title":"Function after intersphincteric resection for low rectal cancerand its influence on quality of life","volume":"13","author":"Barisic","year":"2011","journal-title":"Color Dis"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nmo.13241","article-title":"Relationship between symptoms and quality of life in fecal incontinence","volume":"30","author":"Bedard","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0051","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: Development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"Emmertsen","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0052","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.juro.2017.03.121","article-title":"Interpreting patient-reported urinary and sexual function outcomes across multiple validated instruments","volume":"3","author":"Vertosick","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0053","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-019117","article-title":"Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: A meta-analysis protocol","volume":"8","author":"Musoro","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2012.04.018","article-title":"Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer","volume":"103","author":"Barraclough","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.09.071_bib0056","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","article-title":"Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study","volume":"7","author":"Basch","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622033958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622033958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:05:46Z","timestamp":1759745146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622033958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0360301622033958"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.09.071","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Year Treatment-Related Side Effects and Quality of Life After Chemoradiotherapy in Squamous Cell Carcinoma of the Anus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.09.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}